These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 23615041)
1. Differential significance of plasma visfatin concentrations according to adiposity in children and adolescents. Kim HJ; Park SY; Choi YJ; Han SJ; Lee KW; Kim DJ Horm Res Paediatr; 2013; 79(4):208-13. PubMed ID: 23615041 [TBL] [Abstract][Full Text] [Related]
2. Plasma visfatin concentration as a surrogate marker for visceral fat accumulation in obese children. Araki S; Dobashi K; Kubo K; Kawagoe R; Yamamoto Y; Kawada Y; Asayama K; Shirahata A Obesity (Silver Spring); 2008 Feb; 16(2):384-8. PubMed ID: 18239648 [TBL] [Abstract][Full Text] [Related]
3. The relationship between circulating visfatin/nicotinamide phosphoribosyltransferase, obesity, inflammation and lipids profile in elderly population, determined by structural equation modeling. Owczarek AJ; Olszanecka-Glinianowicz M; Kocełak P; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Puzianowska-Kuźnicka M; Grodzicki T; Więcek A; Chudek J Scand J Clin Lab Invest; 2016 Dec; 76(8):632-640. PubMed ID: 27712122 [TBL] [Abstract][Full Text] [Related]
4. Visfatin in obese children and adolescents and its association with insulin resistance and metabolic syndrome. Nourbakhsh M; Nourbakhsh M; Gholinejad Z; Razzaghy-Azar M Scand J Clin Lab Invest; 2015 Apr; 75(2):183-8. PubMed ID: 25723377 [TBL] [Abstract][Full Text] [Related]
5. Body fat distribution has no effect on serum visfatin levels in healthy female subjects. Ersoy C; Sadikoglu G; Orhan H; Guclu M; Sarandol E; Akgun MD; Ozcakir A; Imamoglu S Cytokine; 2010 Mar; 49(3):275-8. PubMed ID: 20045351 [TBL] [Abstract][Full Text] [Related]
6. Visfatin is associated with lipid metabolic abnormalities in Lyon hypertensive rats. Wang P; Bai C; Xu QY; Xu TY; Su DF; Sassard J; Miao CY Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):894-9. PubMed ID: 20456420 [TBL] [Abstract][Full Text] [Related]
7. Interactions between adiponectin, visfatin, and omentin in subcutaneous and visceral adipose tissues and serum, and correlations with clinical and peripheral metabolic factors. Sitticharoon C; Nway NC; Chatree S; Churintaraphan M; Boonpuan P; Maikaew P Peptides; 2014 Dec; 62():164-75. PubMed ID: 25453978 [TBL] [Abstract][Full Text] [Related]
8. Epicardial fat thickness: relationship with plasma visfatin and plasminogen activator inhibitor-1 levels in visceral obesity. Malavazos AE; Ermetici F; Cereda E; Coman C; Locati M; Morricone L; Corsi MM; Ambrosi B Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):523-30. PubMed ID: 18083357 [TBL] [Abstract][Full Text] [Related]
9. The relationship of visfatin/pre-B-cell colony-enhancing factor/nicotinamide phosphoribosyltransferase in adipose tissue with inflammation, insulin resistance, and plasma lipids. Chang YC; Chang TJ; Lee WJ; Chuang LM Metabolism; 2010 Jan; 59(1):93-9. PubMed ID: 19765775 [TBL] [Abstract][Full Text] [Related]
10. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Berndt J; Klöting N; Kralisch S; Kovacs P; Fasshauer M; Schön MR; Stumvoll M; Blüher M Diabetes; 2005 Oct; 54(10):2911-6. PubMed ID: 16186392 [TBL] [Abstract][Full Text] [Related]
11. Are plasma levels of visfatin and retinol-binding protein 4 (RBP4) associated with body mass, metabolic and hormonal disturbances in women with polycystic ovary syndrome? Olszanecka-Glinianowicz M; Madej P; Zdun D; Bożentowicz-Wikarek M; Sikora J; Chudek J; Skałba P Eur J Obstet Gynecol Reprod Biol; 2012 May; 162(1):55-61. PubMed ID: 22397743 [TBL] [Abstract][Full Text] [Related]
12. Association of circulating visfatin concentrations with insulin resistance and low-grade inflammation after dietary energy restriction in Spanish obese non-diabetic women: role of body composition changes. Agueda M; Lasa A; Simon E; Ares R; Larrarte E; Labayen I Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):208-14. PubMed ID: 20951014 [TBL] [Abstract][Full Text] [Related]
13. Plasma visfatin concentrations increase in both hyper and hypothyroid subjects after normalization of thyroid function and are not related to insulin resistance, anthropometric or inflammatory parameters. Caixàs A; Tirado R; Vendrell J; Gallart L; Megía A; Simón I; Llauradó G; González-Clemente JM; Giménez-Palop O Clin Endocrinol (Oxf); 2009 Nov; 71(5):733-8. PubMed ID: 19222486 [TBL] [Abstract][Full Text] [Related]
14. The effect of sodium restricted diet on plasma visfatin levels in hypertensive patients with visceral obesity. Rotkegel S; Chudek J; Spiechowicz-Zaton U; Ficek R; Adamczak M; Wiecek A Kidney Blood Press Res; 2013; 37(2-3):124-31. PubMed ID: 23615125 [TBL] [Abstract][Full Text] [Related]
15. Visfatin levels in prepubertal children born small or large for gestational age. Giapros VI; Kiortsis DN; Evagelidou EN; Challa AS; Cholevas VK; Siomou EC; Bairaktari ET; Andronikou SK Horm Metab Res; 2012 Feb; 44(2):135-9. PubMed ID: 22314334 [TBL] [Abstract][Full Text] [Related]
16. Circulating visfatin level is correlated with inflammation, but not with insulin resistance. Oki K; Yamane K; Kamei N; Nojima H; Kohno N Clin Endocrinol (Oxf); 2007 Nov; 67(5):796-800. PubMed ID: 17634078 [TBL] [Abstract][Full Text] [Related]
17. Serum visfatin levels, adiposity and glucose metabolism in obese adolescents. Taşkesen D; Kirel B; Us T J Clin Res Pediatr Endocrinol; 2012 Jun; 4(2):76-81. PubMed ID: 22672864 [TBL] [Abstract][Full Text] [Related]
18. Elevated visfatin levels in obese children are related to proinflammatory factors. Li RZ; Ma Xn; Hu XF; Kang SX; Chen SK; Cianflone K; Lu HL J Pediatr Endocrinol Metab; 2013; 26(1-2):111-8. PubMed ID: 23327785 [TBL] [Abstract][Full Text] [Related]
19. Correlations between the expression of the insulin sensitizing hormones, adiponectin, visfatin, and omentin, and the appetite regulatory hormone, neuropeptide Y and its receptors in subcutaneous and visceral adipose tissues. Nway NC; Sitticharoon C; Chatree S; Maikaew P Obes Res Clin Pract; 2016; 10(3):256-63. PubMed ID: 26067914 [TBL] [Abstract][Full Text] [Related]
20. Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans. Pagano C; Pilon C; Olivieri M; Mason P; Fabris R; Serra R; Milan G; Rossato M; Federspil G; Vettor R J Clin Endocrinol Metab; 2006 Aug; 91(8):3165-70. PubMed ID: 16720654 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]